Why does Pharma Need to Relook at its Patient Engagement and Support Strategies?

Why does Pharma Need to Relook at its Patient Engagement and Support Strategies?

Recently, I was reading Luca Dezzani’s article “Patient Engagement: A Key Element in Pharmaceutical Marketing Strategy.” The article prompted me to think about how pharma companies continue to think about and discuss the idea of Patient Engagement, and.... Read More »

Building Regulatory Affairs: Efficiency Quadrant that Drives Spend

Building Regulatory Affairs: Efficiency Quadrant that Drives Spend

Best Practices, LLC has recently completed “Benchmarking Regulatory Affairs Staffing & Performance Excellence in Medical Devices,” a new operational benchmarking study. After analyzing the data and probing the experience of 30 regulatory affairs (RA).... Read More »

Blockbuster Launch Evolution: Learning to See the Market in Different Wavelengths and Perspectives (Part 2)

Blockbuster Launch Evolution: Learning to See the Market in Different Wavelengths and Perspectives (Part 2)

One of the areas within the Pharmaceutical and related industries which has the main goal of seeing market opportunities is the Market Research function. Despite this, many organizations’ Market Research groups do not have 20/20 vision. Read More »

New Series: Blockbuster Pharmaceutical Drugs Launch Evolution (Part-1)

New Series: Blockbuster Pharmaceutical Drugs Launch Evolution (Part-1)

At Pharma CI Conference 2015 in New Jersey, Best Practices, LLC’s CEO, Chris Bogan discussed the topic: Blockbuster Drugs Launch Evolution: Mapping Market - Entry Changes That Cause New Products to Stumble or Soar.... Read More »

Relationships Matter: To be Effective, Medical Information Groups in Pharmaceutical Companies Must Forge Collaborative Relationships with other Internal Groups such as Legal

Relationships Matter: To be Effective, Medical Information Groups in Pharmaceutical Companies Must Forge Collaborative Relationships with other Internal Groups such as Legal

Within the pharmaceutical sector, medical information groups shoulder great responsibilities. The principal role of medical information groups, which are typically part of the medical affairs organization, is responding to questions about products from external groups such as physicians. Read More »

Achieving Better Advocacy Group Relationships a Critical Piece of Resurgent Disease State Awareness Drive in Pharmaceutical Industry

Achieving Better Advocacy Group Relationships a Critical Piece of Resurgent Disease State Awareness Drive in Pharmaceutical Industry

When it comes to informing physicians and patients about new therapies, disease awareness programs have experienced a rebirth in the pharmaceutical industry. Read More »

How Can Pharma Leverage the Health Outcomes Liaison Function for Maximum Impact?

How Can Pharma Leverage the Health Outcomes Liaison Function for Maximum Impact?

With the shift toward evidence-based medicine and value-based pricing in the health care industry, bio-pharmaceutical organizations have turned to Health Outcomes Liaisons (HOLs) to serve as a scientific bridge with payer organizations, thought leaders, and other important decision makers. Read More »

Brand Lifecycle Management: Strategies for Every Budget

Brand Lifecycle Management: Strategies for Every Budget

Many pharmaceutical companies use strategies to extend the commercial life of mature pharmaceutical brands and minimize market share decline, but Best Practices LLC and RxSolutions have identified superior strategies across different investment levels from survey results of 25 executives representing 18 companies. Read More »

 

Hotspots in Biopharma Digital Marketing Innovation

The rapid growth of digital, mobile and related technologies has transformed the global communications paradigm, and with it, changed the ways in which consumers and professionals access information. In case of the biopharmaceutical and medical device industry, the development of

Adopting the New Patient Journey Framework for Marketing

Marketing within the healthcare industry has been rapidly changing due to the growing influence of patients. Physicians are no longer the main focus in marketing when trying to determine market access and product launch success. Because patients are becoming more

Can Sovaldi’s Launch Success Be Repeated? Examining How Gilead Sciences Utilized Marketing Mix To Rewrite Launch History

We all know this story: Ninety-five percent of drugs in the development pipeline fail to clear the safety and efficacy profiles, and companies then add that R&D cost of such failures to the price of the drug that does reach the

Creating and Maintaining a Strategic KOL Management and Engagement System

Across the pharmaceutical sector, regulatory and access issues have reshaped interactions with Key Opinion Leaders (KOLs). And with KOL interactions affecting everything from clinical development to product launch, the issue of strategically managing these critical exchanges looms large for small

Role of Medical Affairs Increasing in Oncology Launch

The Medical Affairs function plays a vital role in a host of oncology activities, including identification and engagement of Key Thought Leaders to guidance of commercial strategies and launch resources management. It is becoming increasingly apparent that a successful launch

Frustrations of a Pharmaceutical Market Researcher…

Not that long ago, I was updating a key research project here at Best Practices; and as usual, I was waiting on approval from our research manager. The approval delay made me agitated, but not nearly as much as when

Best Practices Hosts 7th Digital Marketing Consortium Roundtable

Best Practices hosted our 7th Digital Marketing Consortium Roundtable on Thursday, July 23. The topic of the virtual conference was “Key Trends & Innovative Activities in 2015 Biopharma Digital Marketing.” The roundtable brought together executives from 8 leading pharmaceutical companies

Overcoming Regulatory Risks and Gaining Critical Insights through Social Media Listening

The pharmaceutical industry as a whole has struggled to delve into the social media world. The main reason for this is due to regulatory restrictions, with organizations fearful to engage in online conversations with patients due to the perceived high

Seven Important Steps to Seamless Pharmaceutical Advisory Board Management

Pharmaceutical and medical device companies seeking guidance on clinical trials, marketing campaigns assessment, or product reimbursement strategies turn towards the expertise provided by key advisory boards. However, managing successful advisory boards today comes at a cost, which can be anywhere

Best Practices Hosting 6th Medical Affairs Consortium on HEOR

Best Practices will be hosting the sixth roundtable of our Medical Affairs Consortium on Thursday (May 28th) from 11:00AM-12:30PM (EST) via a virtual roundtable to discuss “Medical Affairs’ Role in Health Economics & Outcomes Research.” This is the final roundtable

As Mobile Surpasses Desktop Search, Poll of Digital Marketers Finds Industry Divided on Pharma’s Next Steps

In a digital advertising conference yesterday, Google announced that mobile searches have surpassed desktop searches in the U.S. and numerous other countries. This is big news, but a not necessarily stunning development to anyone paying close attention to the inexorable

New Study Published: Advisory Board Management at Large Pharma & Device Companies

Best Practices, LLC just published a new research report on Advisory Board Management. The report examines how Advisory Boards at large, mid-cap, and small companies are able to organize, recruit and plan such critical product shaping think tanks. An effective

One Way to Please the Boss (& the Boss’s Boss): Crafting Highly Effective Executive Briefs

A quick peek behind the curtain at the Best Practices Research Center and a Most Interesting Case that recently landed on my desk. We are a consulting firm whose clients work mainly in the pharma and biotech sector.  As a

Exclusive: Key Findings from Best Practices’ 5th Medical Affairs Consortium

Best Practices recently completed the second roundtable of our 2014-2015 Medical Affairs Consortium. The roundtable addressed the topic of “Medical Affairs Launch Support.” The roundtable brought together executives from 13 leading pharmaceutical organizations. Some exclusive key findings from the discussion